Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia.

Identifieur interne : 004361 ( Main/Exploration ); précédent : 004360; suivant : 004362

Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia.

Auteurs : R. Noordin [Malaisie] ; J. Muhi ; Z. Md Idris ; N. Arifin ; A. Kiyu

Source :

RBID : pubmed:22543621

Descripteurs français

English descriptors

Abstract

The detection rates of brugian filariasis in three regions of Sarawak namely Central, North and South after three courses of mass drug administration (MDA) from year 2004 to 2006 was investigated. A recombinant BmR1 antigen-based IgG4 detection test, named Brugia Rapid and night blood smear for microfilaria (mf) detection were used. All three regions recorded a sharp fall in mf positive rates after a year post-MDA. Meanwhile Brugia Rapid positive rates declined more gradually to 3.8% and 5.6% of the pre-MDA levels in the Central and North regions, respectively. This study showed that in filariasis endemic areas in Sarawak, anti-filarial IgG4 antibodies to BmR1, as detected by the Brugia Rapid test, were positive for one to two years after mf disappearance.

PubMed: 22543621


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia.</title>
<author>
<name sortKey="Noordin, R" sort="Noordin, R" uniqKey="Noordin R" first="R" last="Noordin">R. Noordin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang, Malaysia. rahmah8485@gmail.com</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang</wicri:regionArea>
<wicri:noRegion>Penang</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muhi, J" sort="Muhi, J" uniqKey="Muhi J" first="J" last="Muhi">J. Muhi</name>
</author>
<author>
<name sortKey="Md Idris, Z" sort="Md Idris, Z" uniqKey="Md Idris Z" first="Z" last="Md Idris">Z. Md Idris</name>
</author>
<author>
<name sortKey="Arifin, N" sort="Arifin, N" uniqKey="Arifin N" first="N" last="Arifin">N. Arifin</name>
</author>
<author>
<name sortKey="Kiyu, A" sort="Kiyu, A" uniqKey="Kiyu A" first="A" last="Kiyu">A. Kiyu</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22543621</idno>
<idno type="pmid">22543621</idno>
<idno type="wicri:Area/PubMed/Corpus">002146</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002146</idno>
<idno type="wicri:Area/PubMed/Curation">002146</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002146</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002146</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002146</idno>
<idno type="wicri:Area/Ncbi/Merge">004D20</idno>
<idno type="wicri:Area/Ncbi/Curation">004D20</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D20</idno>
<idno type="wicri:doubleKey">0127-5720:2012:Noordin R:duration:of:detection</idno>
<idno type="wicri:Area/Main/Merge">004379</idno>
<idno type="wicri:Area/Main/Curation">004361</idno>
<idno type="wicri:Area/Main/Exploration">004361</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia.</title>
<author>
<name sortKey="Noordin, R" sort="Noordin, R" uniqKey="Noordin R" first="R" last="Noordin">R. Noordin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang, Malaysia. rahmah8485@gmail.com</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang</wicri:regionArea>
<wicri:noRegion>Penang</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muhi, J" sort="Muhi, J" uniqKey="Muhi J" first="J" last="Muhi">J. Muhi</name>
</author>
<author>
<name sortKey="Md Idris, Z" sort="Md Idris, Z" uniqKey="Md Idris Z" first="Z" last="Md Idris">Z. Md Idris</name>
</author>
<author>
<name sortKey="Arifin, N" sort="Arifin, N" uniqKey="Arifin N" first="N" last="Arifin">N. Arifin</name>
</author>
<author>
<name sortKey="Kiyu, A" sort="Kiyu, A" uniqKey="Kiyu A" first="A" last="Kiyu">A. Kiyu</name>
</author>
</analytic>
<series>
<title level="j">Tropical biomedicine</title>
<idno type="ISSN">0127-5720</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Antibodies, Helminth (blood)</term>
<term>Antigens, Helminth</term>
<term>Brugia (immunology)</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Drug Therapy (methods)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (immunology)</term>
<term>Filaricides (administration & dosage)</term>
<term>Humans</term>
<term>Immunoglobulin G (blood)</term>
<term>Malaysia (epidemiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Recombinant Proteins</term>
<term>Seroepidemiologic Studies</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Anticorps antihelminthe (sang)</term>
<term>Antigènes d'helminthe</term>
<term>Brugia (immunologie)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs temps</term>
<term>Filaricides (administration et posologie)</term>
<term>Filariose lymphatique (immunologie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Immunoglobuline G (sang)</term>
<term>Jeune adulte</term>
<term>Malaisie (épidémiologie)</term>
<term>Mâle</term>
<term>Protéines recombinantes</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Traitement médicamenteux ()</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Helminth</term>
<term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Malaysia</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Brugia</term>
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Brugia</term>
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Drug Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Anticorps antihelminthe</term>
<term>Immunoglobuline G</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Filariose lymphatique</term>
<term>Malaisie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Antigens, Helminth</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Recombinant Proteins</term>
<term>Seroepidemiologic Studies</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Antigènes d'helminthe</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Protéines recombinantes</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Traitement médicamenteux</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Malaisie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The detection rates of brugian filariasis in three regions of Sarawak namely Central, North and South after three courses of mass drug administration (MDA) from year 2004 to 2006 was investigated. A recombinant BmR1 antigen-based IgG4 detection test, named Brugia Rapid and night blood smear for microfilaria (mf) detection were used. All three regions recorded a sharp fall in mf positive rates after a year post-MDA. Meanwhile Brugia Rapid positive rates declined more gradually to 3.8% and 5.6% of the pre-MDA levels in the Central and North regions, respectively. This study showed that in filariasis endemic areas in Sarawak, anti-filarial IgG4 antibodies to BmR1, as detected by the Brugia Rapid test, were positive for one to two years after mf disappearance.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Malaisie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Arifin, N" sort="Arifin, N" uniqKey="Arifin N" first="N" last="Arifin">N. Arifin</name>
<name sortKey="Kiyu, A" sort="Kiyu, A" uniqKey="Kiyu A" first="A" last="Kiyu">A. Kiyu</name>
<name sortKey="Md Idris, Z" sort="Md Idris, Z" uniqKey="Md Idris Z" first="Z" last="Md Idris">Z. Md Idris</name>
<name sortKey="Muhi, J" sort="Muhi, J" uniqKey="Muhi J" first="J" last="Muhi">J. Muhi</name>
</noCountry>
<country name="Malaisie">
<noRegion>
<name sortKey="Noordin, R" sort="Noordin, R" uniqKey="Noordin R" first="R" last="Noordin">R. Noordin</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004361 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004361 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:22543621
   |texte=   Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22543621" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024